Discover what it takes to optimize clinical trial performance and efficiency _________________________________
Anita Nelsen is the senior vice president of clinical trial operations at Allucent, a global CRO focused on small and mid-sized biotech companies that offers a full spectrum of integrated services to support drug R&D. In an interview, Nelsen discussed some of the challenges these smaller life science companies face in a post-Covid world – ranging from funding to supply chain complexities – and how these companies can benefit from expert guidance to see them through today's drug development environment. Read our conversation here. |
|
No comments